- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06548295
Effects of mCIMT vs CT on Upper Extremity Motor Function and ADLs in Chronic Stroke Patients
Effects of Modified Constraint Induced Movement Therapy (mCIMT) Versus Conservative Treatment on Upper Extremity Motor Function and ADLs in Chronic Stroke Patients
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sialkot, Pakistan
- Little angles home aziz bhati shaheed road opposit junior aps
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants will be under the age of 40-75 years
- Diagnosis: stroke
Exclusion Criteria:
- patients suffering from motor dysfunction due to other diseases (e.g., cerebral palsy, traumatic brain injury, and Parkinson's disease
- Balance problem
- Rheumatic diseases
- High spasticity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: modified constraint induced movement therapy (mCIMT)
|
Restraint the involved extremity by using a mitten. Repetitive task practice i.e filling a glass, drinking a glass of water, and eating with a spoon , stacking cones and stacking blocks, grasping and releasing of an object, reaching forward and sideways, lifting and dropping of an object from the one end of table to the other end. The shaping exercises included cube stacking, card turning, throwing balls into a box, grasping/holding and placing objects of different sizes, and drawing and painting exercises. Intervention: 5 sessions per week for 50 minutes for 6 weeks |
|
Experimental: conservative treatment
|
The conservative rehabilitation program consisted of upper-limb range of motion exercises, positioning, stretching, and strengthening exercises, Passive mobilization of the shoulder ,elbow , wrist and small joints of hand Stretching of the affected arm including biceps, triceps and muscles of forearm and hand. Strengthening exercises of upper arm and forearm muscles involved. Intervention: 5 sessions per week for six weeks and 50 mintues |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barthal index
Time Frame: 12 Months
|
Barthel Index (BI) stands out as a widely utilized measure for assessing basic activities of daily living (ADL).
Scores of 0-20 indicate "total" dependency.
Scores of 21-60 indicate "severe" dependency.
Scores of 61-90 indicate "moderate" dependency.
|
12 Months
|
|
The use of FMA-UE
Time Frame: 12 months
|
measureing comprising 30 items for motor function and 3 items for reflex function, provides a comprehensive evaluation of motor abilities . In regards to UE feature, 33 elements evaluate motor function, six items assess sensitivity and proprioception, while the last 24 points rate joint pain and mobility. Every item of the assessment scale is marked on an ordinal level, from 0 to 2; the 0 value corresponds with the impossibility to perform a movement, and 2 represents the ability to perform a complete and adequate movement |
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSRSW/Batch-Fall22/733
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Stroke
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Karabuk UniversityRecruitingChronic StrokeTurkey (Türkiye)
-
Marina Castel SánchezNot yet recruiting
-
Karabuk UniversityRecruiting
-
Zikra AzharRecruitingChronic StrokePakistan
-
Sierra Varona SLNot yet recruiting
-
Montiha AzeemRecruitingChronic Ischemic StrokePakistan
-
Riphah International UniversityNot yet recruitingChronic Stroke PatientsPakistan
-
HealthPartners InstituteRecruitingChronic Stroke PatientsUnited States
-
Nisha FazalRecruiting
Clinical Trials on modified constraint induced movement therapy (mCIMT)
-
University Hospital of North NorwayHelse NordTerminated
-
CEU San Pablo UniversityCompleted
-
Shirley Ryan AbilityLabCompletedCerebral Palsy | Hemiplegia | Hemiparesis | Speech and Language DisorderUnited States
-
Nova Scotia Health AuthorityDalhousie University; Sunnybrook Research InstituteCompleted
-
Abant Izzet Baysal UniversityCompletedSpastic Hemiplegic Cerebral PalsyTurkey
-
NCS University SystemNot yet recruiting
-
Muş Alparlan UniversityCompletedHemiplegia; CongenitalTurkey
-
Istanbul UniversityUnknownStroke PatientsTurkey
-
Universita di VeronaCompleted
-
Health Education Research Foundation (HERF)CompletedHemiplegic Cerebral PalsyPakistan